Law & policy

Latest content

US Federal Trade Commission set to tighten screws on patent strategies

New policy statement likely to target pay-for-delay deals and sham litigation

18 November 2022

US congressional election results are good omen for Section 101 reform efforts

Panellists at IAM’s Patent Policy and Litigation USA event are hopeful in view of Senator Chris Coons being poised to take leadership of the Senate IP Subcommittee

17 November 2022

Ruling opens the door to protecting room design under the Copyright Act

A fresh decision from the IP and Commercial Court could mark major changes for the Taiwanese hotel industry by extending copyright protection to encompass room configurations.

16 November 2022

Food for thought: complexities behind protecting food-related intellectual property in India

The lack of specific trade secret legislation and definition of a ‘fixed form’ in India presents challenges to how edible creative work can be protected.

16 November 2022

UPC judge conflict-of-interest risks must be handled with extreme care

Saturday Opinion: The new court must take decisive and transparent action to address concerns about part-time judges

12 November 2022

Analysing IP impact of US midterms as results unfold

While final outcomes are still pending, outlook suggests strong IP policy impact

11 November 2022

Government initiatives spark Indian Patent Office overhaul

The Indian government’s constant focus on strengthening the country’s IP ecosystem has brought about major improvements in the way that patents are filed, prosecuted and enforced – but more still needs to be done.

09 November 2022

Moderna attempt to deflect covid infringement suits to US government takes a setback

District Court in Delaware rebuffs company’s attempt to deny liability in the latest development of the increasingly complex mRNA patent wars

08 November 2022

Farewell, Fintiv discretionary denials

Docket Navigator data shows the drastic impact that USPTO Director Kathi Vidal’s new discretionary denial policies have had at the PTAB

07 November 2022

SCOTUS to review Patent Act enablement standard for first time in more than 70 years

Surprise decision to hear Amgen’s appeal follows Solicitor General advice not to grant certiorari

07 November 2022

Unlock unlimited access to all IAM content